Last $10.75 USD
Change Today +0.43 / 4.17%
Volume 1.5M
INO On Other Exchanges
Symbol
Exchange
NYSE Amex
Frankfurt
As of 8:04 PM 08/27/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Angel Cabrera Ph.D.

Director, Chairman of Nomination & Corporate Governance Committee and Member of Audit Committee, Inovio Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 10 board members in 1 different organizations across 1 different industries.

See Board Relationships
46$86,433

Background*

Dr. Angel Cabrera, Ph.D. is an Advocate of Corporate Social Responsibility and Managerial Professionalism. Dr. Cabrera is outgoing President of the Thunderbird School of Global Management, widely regarded as the world's leading graduate school of international business. During his eight-year term, Dr. Cabrera led a major academic, operational and financial overhaul of the international business school, stemming operating deficits and declining revenues and consolidating ...

Read Full Background

Corporate Headquarters*

Building 18
Blue Bell, Pennsylvania 19422

United States

Phone: 267-440-4200
Fax: 267-440-4242

Board Members Memberships*

2012-Present
Director, Chairman of Nomination & Corporate Governance Committee and Member of Audit Committee

Education*

Unknown/Other Education
Carnegie Mellon University
MS
Georgia Institute of Technology
PhD
Georgia Institute of Technology
MS
Universidad Politécnica de Madrid
BS
Universidad Politécnica de Madrid
Unknown/Other Education
John F. Kennedy School of Government

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$67,000
Total Calculated Compensation$86,433
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INO:US $10.75 USD +0.43

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Vijay B. Samant Chief Executive Officer, President, Acting Chief Financial Officer and Director
Vical Incorporated
$557.0K
Steven W. King Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc
Peregrine Pharmaceuticals, Inc.
$445.8K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Philippe Archinard Ph.D.Chairman and Chief Executive Officer
Transgene SA
€72.2K
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
$533.3K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INOVIO PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.